Tethered Cord & Spinal Dysraphism Case Review Coordination

• Age at diagnosis and suspected congenital or acquired cause.
• Date and progression of pain, weakness, numbness, gait, bladder and bowel symptoms.
• Activities, growth periods, pregnancy, trauma or previous surgery associated with change.
• Baseline and current walking distance, stairs, running, transfers, falls, school, work and self-care.
• Gait videos and previous functional assessments where available.
• Patient- and family-defined goals and the functions they most need to preserve or improve.

• Serial strength, tone, reflex, coordination and sensory examinations.
• Perineal or saddle sensation and sacral neurological findings where clinically documented.
• Motor-development and school-function records in children.
• Physical and occupational therapy reports.
• Mobility aids, orthoses and changes in independence.
• Pain distribution, neuropathic features and response to prior pain treatment.

• Original lumbosacral and relevant whole-spine MRI DICOM files.
• Radiology reports and all earlier scans for comparison.
• Conus level, filum appearance, lipoma or neural placode anatomy, split cord, dermal sinus, dermoid or epidermoid lesion.
• Syrinx, scoliosis, spinal stenosis, postoperative adhesion and other possible causes of symptoms.
• Pre- and postoperative imaging after prior dysraphism or detethering surgery.
• Ultrasound records in young infants where performed.

Conus level and filum thickness are pieces of the anatomical assessment; neither is a stand-alone test for active tethered cord syndrome.

• Toilet-training and continence history.
• Urgency, frequency, leakage, retention, straining and sensation of incomplete emptying.
• Clean intermittent catheterization schedule, catheter volumes and changes over time.
• Urinary tract infection history and culture results.
• Post-void residuals, renal and bladder ultrasound, renal function and upper urinary-tract findings.
• Urodynamic reports, tracings and comparison with previous studies where possible.
• Anticholinergic, beta-3 agonist, botulinum toxin or reconstructive urological treatment history.

Urodynamics evaluates lower urinary-tract function and risk; it does not independently prove that tethering is the cause of an abnormal result.

• Constipation, incontinence, sensation, evacuation and bowel-program history.
• Medications, irrigation, enemas, antegrade continence procedures or ostomy records.
• Pelvic-floor, colorectal and gastroenterology assessments where relevant.
• Sexual or reproductive symptoms in adults when clinically relevant.
• Alternative gastrointestinal or pelvic-floor explanations already assessed.

• Foot shape, asymmetry, weakness, contracture, clubfoot or cavus progression.
• Hip, knee and limb-length assessment.
• Standing spinal radiographs and serial Cobb-angle measurements.
• Brace, casting, orthotic and previous orthopaedic surgery history.
• Relationship between orthopaedic change and neurological or urological deterioration.

• Clinical photographs where appropriate and consented.
• Location and appearance of dimples, openings, hair tufts, haemangiomas, subcutaneous masses or drainage.
• History of redness, swelling, discharge, fever, meningitis or local infection.
• Ultrasound, MRI and surgical records relating to a sinus tract or inclusion lesion.

A true congenital dermal sinus can communicate deeply and carries infection risk. Active drainage or systemic illness requires prompt local assessment.

• Original myelomeningocele, lipoma, split-cord, dermal-sinus or filum operative report.
• Extent of detethering or lipoma resection and reconstruction technique.
• Intraoperative neurophysiological monitoring report where available.
• CSF leak, infection, wound breakdown, new neurological deficit and early recovery.
• Duration and degree of symptom improvement or stabilization.
• Later retethering episodes, reoperations and accumulated scar burden.

• Myelomeningocele level and prenatal or postnatal closure records.
• Hydrocephalus, shunt model, valve setting and malfunction history.
• Chiari II, syringomyelia and brainstem symptom records.
• Pressure-injury, latex-allergy, bone-health and mobility history.
• Current spina bifida multidisciplinary care plan.

• Major medical conditions, anaesthetic history, anticoagulation, infection and wound-healing risks.
• Renal status and bladder-safety priorities.
• Baseline deficits that may not be reversible.
• Travel fitness and family or caregiver support.
• Access to local neurosurgery, urology, rehabilitation, orthopaedics and emergency care.
• Understanding that the goal may be stabilization rather than complete symptom reversal.

Anatomical attachment can be visible in a low conus, fatty or thickened filum, spinal lipoma, split cord, dermal sinus, repaired myelomeningocele or postoperative scar. Active tethered cord syndrome is considered when a compatible pattern of neurological, urological, orthopaedic, pain or functional deterioration is plausibly linked to that anatomy. Stable anatomy and long-standing deficits should not automatically be labelled progressive syndrome.

MRI helps define the conus, filum, lipoma, neural placode, split cord, inclusion lesion, syrinx and previous operative field. Diagnostic performance varies by the anatomical question and reference standard. A normal or borderline conus does not prove occult tethering, while a low conus does not prove that current pain or bladder symptoms are caused by tethering. Longitudinal clinical information is essential.

Children may show new weakness, altered gait, reduced endurance, asymmetric foot growth, deformity, scoliosis progression, delayed or lost continence, recurrent urinary infection or changing urodynamics. Growth can coincide with presentation, but deterioration should be documented rather than assumed. Development, mobility, bladder, kidney and orthopaedic outcomes require coordinated surveillance.

Adults may present with pain, sensory change, weakness, gait limitation, bladder or bowel dysfunction, sometimes after a congenital lesion was previously unrecognized or after earlier surgery. Degenerative stenosis, disc disease, peripheral neuropathy, hip pathology, pelvic-floor dysfunction, urological disease and chronic pain mechanisms can mimic or coexist with tethering. The treatment plan should address the condition most likely to explain progressive loss of function.

Urodynamic testing can characterize storage pressure, compliance, detrusor activity, sphincter coordination and emptying. Its role is strongest when interpreted with symptoms, catheter volumes, residual urine, infection history, renal imaging, previous studies and the broader neuro-urological plan. Deteriorating bladder safety may require action, but an isolated abnormal study is not a specific diagnostic test for tethered cord.

Occult tethered cord syndrome is a disputed hypothesis used for selected patients with compatible symptoms but a normally positioned conus and no classic tethering lesion. There is no universally accepted diagnostic definition, and pain, bladder, bowel and fatigue symptoms can arise from many other conditions. Normal MRI does not establish occult tethering, and urodynamic abnormality is not specific.

Published surgical literature is heterogeneous and vulnerable to selection bias, variable diagnostic criteria and inconsistent outcomes. Any proposal for filum section in this setting should include multidisciplinary exclusion of alternative causes, objective baseline measures, explicit discussion of uncertainty, realistic goals and careful informed consent. It should not be presented as an established or predictable pathway.

A fatty or thickened filum may be part of a tethering anatomy, but imaging appearance alone does not determine treatment. When a specialist team concludes that a relatively isolated filum is causing a compatible progressive syndrome, sectioning can be technically different from complex lipoma or retethering surgery. Risks still include CSF leak, infection, neurological injury, wound problems and later retethering, and symptom improvement is not guaranteed.

Spinal lipomas vary greatly in their relationship to the conus, roots and neural placode. Management of an asymptomatic or minimally symptomatic infant or child remains debated and depends on anatomy, baseline neurological and urological function, natural-history estimates, surgical philosophy and family preferences. Observation and prophylactic surgery both require transparent discussion of uncertain long-term comparative evidence.

Partial, subtotal and more extensive lipoma-resection strategies are not interchangeable. More extensive reconstruction may aim to reduce future tethering in selected anatomy but can add operative complexity and neurological risk. These decisions belong in experienced pediatric dysraphism centres.

Split cord malformation can involve a bony or fibrous septum and associated tethering. Congenital dermal sinus can extend into the spinal canal and may be associated with dermoid or epidermoid lesions, infection and meningitis. These are not equivalent to an incidental simple sacral dimple. Surgical timing and extent depend on anatomy, symptoms and infection risk.

After myelomeningocele closure, postoperative attachment is common and imaging often remains abnormal. Symptomatic retethering is a clinical deterioration diagnosis, not simply an MRI diagnosis. New weakness, gait or orthopaedic change, pain or bladder deterioration should prompt review of shunt function, hydrocephalus, Chiari II, syrinx, infection, fractures, pressure injury and other causes before reoperation is selected.

Simple first-time filum section, complex lipoma dissection and reoperation through a scarred myelomeningocele or prior detethering field have different technical and outcome profiles. Re-untethering can carry increased risk of root or conus injury, new motor or bladder deficit, CSF leak, wound complication and further retethering. The intended benefit may be stabilization rather than reversal of established impairment.

Electrophysiological monitoring and direct stimulation can help identify functional neural tissue and distinguish it from a non-neural filum or scar during selected operations. Monitoring supports intraoperative decision-making but cannot eliminate neurological risk or guarantee complete safe detethering. Its role and modalities vary with lesion complexity and centre practice.

Pain may improve more readily than long-standing motor, sensory or bladder deficits in some series, but outcomes vary by age, anatomy, symptom duration, previous surgery and measurement method. Surgery may be offered to preserve remaining function or slow decline rather than restore normal function. The available evidence includes substantial heterogeneity, and families should not be promised continence, pain freedom, normalized gait or prevention of all future retethering.

Scar formation and recurrent tethering can occur after any detethering operation, particularly during growth and after complex dysraphism repair. Follow-up should focus on the patient’s own previous warning pattern and longitudinal motor, gait, urological, renal and orthopaedic changes. Repeat surgery should follow renewed diagnostic review rather than an assumption that recurrent symptoms automatically equal retethering.

Spinal-column shortening indirectly reduces longitudinal tension without dissecting the cord from a heavily scarred operative field. It is a major instrumented spinal procedure described mainly for highly selected recurrent or complex tethering, often in older adolescents or adults. It is not a routine alternative to first-time filum section or standard detethering and carries risks related to blood loss, neurological injury, instrumentation, non-union, deformity and adjacent spinal structures.

Hypermobility, Ehlers–Danlos syndrome, Chiari findings, pain, fatigue or bladder symptoms do not independently establish tethered cord. Associations proposed in selected literature should not be converted into automatic screening or surgical rules. A normal conus plus non-specific symptoms is not sufficient evidence for filum surgery. Complex connective-tissue or craniospinal cases require careful evaluation of competing diagnoses and explicit acknowledgement of evidence limitations.